CATALAYER NEWS
Incyte pulls FDA filing for cancer drug approval over confirmatory study, following Gilead out of the exit - Fierce Biotech
Source: Fierce Biotech · 2022-01-26
Full article text is available in the Catalayer news terminal.
RELATED ON CATALAYER
Mentioned Tickers
$INCY · IncyteRelated Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets